Several from VUMC among most highly cited researchers
Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
Genomic analysis of SCLC tumors reveals subtypes, offers cues toward personalized treatments
The largest genomic analysis ever conducted of small cell lung cancer tumors (SCLC) has identified genetic subtypes and provided insights into the mechanisms of this aggressive and deadly cancer. The study, published recently in Cancer Discovery, reveals cues toward the development of personalized treatment approaches.
Study evaluates polygenic risk score for prostate cancer risk prediction
A prostate cancer polygenic risk score (PRS) has limited utility for enhancing prostate cancer screening, according to a new study published in JAMA Internal Medicine.
Conquer Cancer awards given to five hematology-oncology fellows
Young Investigator Awards provide research funding to promising young physicians during the final years of training to support their transition to a faculty appointment and to encourage quality research in clinical oncology. Yu-Wei Chen, MD, MS; R. Dixon Dorand, MD, PhD, and Brian Grieb, MD, PhD, are recipients of Young Investigator Awards.
National Cancer Institute honors Berlin’s contributions, leadership
Jordan Berlin, MD, Ingram Professor of Cancer Research and director of the Division of Hematology and Oncology, is a 2022 recipient of the National Cancer Institute (NCI) Director’s Award.